ANTIMYCOTIC GEL PREPARATIONS

Abstract: This invention relates to antimycotic gel preparations for external use containing clotrimazole or bifonazole, a carboxy vinyl polymer, an organic amine and 1,3-btitylene glycol.

Description: Antimycotic Gel preparitions This invention relates to antimycotic gel preparations for external use containing clotrimazole or bifonazole, preferably clotrimazole. Clotrimazole has the chemical name of 1- [(2-chloro- phenyl)diphenylmethyl]imidazole, molecular formula C22H17C1N21 molecular weight 344.84, the structure EMI1.1 and has a strong antimycotic action. It has excellent therapeutic effects on tinea pompholyciformis, tinea interdigitalis, tinea cruris, trichophytia meculovesiculosa, etc. Bifonazole has the chemical name 1-[&alpha;-(4-biphenyl)-benzyl]- imidazol, the structure EMI1.2 the molecular formula C22H18N2, the molecular weight 310,4 and has a strong antimycotic action. The present invention provides a bifonazole and preferably a clotrimazole gel preparation which permits excellent penetration and migration (absorption) of the active ingre ent the hugh the skin, and has a good use feeling and ex qrllent tOrage stability, Thus, Ptderding to this invention, there is provided an antimycetic gel preparation characterized by containing bifonazole or preferably clotrimazole, a carboxy vinyl polymer, an organic amine and 1,3-butylene glycol as essential ii édients. It has béen found that 1,3-butylene glycol is a very good solvent for clotrimazole and bifonazole andis especially a pharmaceutically acceptable solvent. 1,3-ButyYene glycol dissolves clotrimazole and bifonazole fairly well, has a high boiling point and therefore hardly vaporizes from the coated surface, and produces an effect of greatly promoting the penetration and migration of clotrimazole and bifonazole through the skin. In the gel preparation of this invention, 1,3-butylene glycol can be used in a proportion of generally 5 to 90% by weight, preferably 30 to 80% by weight, more preferably 40 to 70% by weight, based on the weight of the preparation. 1,3-Butylene glycol is comparatively oleophilic, and upder- goes phase separation when a large quantity of water is added to it. Accordingly, to impove its miscibility with purified water which is optionally used in the gel prepara tion of this invention, the gel preparation may contain ethyl alcohol as required, which, however, is generally used in an amount of not more than 30% by weight based on the weight of the preparation. Depending upon the amount of purified water used, it is convenient to use ethyl alcohol in a proportion of preferably 5 to 30% by weight, more pre ferably 10 to 29% by weight. The gel preparation of this invention uses the carboxy vinyl polymer as a gelling agent. The carboxy vinyl polymer is a hydrophilic (or water-soluble) polymer containing a carboxyl group in the molecule and having a number average molecular weight of usually about 1,000,000 to about 3,000,000, and includes hydrophilic polymers having acrylic acid as a main structural unit (for the properties and other details of the carboxy vinyl polymers, reference may be made to Japanese Standards of Cosmetic Ingredients" edited by Japan Association of Official Publications and Committee of Investigations on the Standards of Cosmetic Ingredients in Central Pharmaceutical Affairs Council, Ministry of Health and Welfare, second edition, Explanation I, pages 272-280, published By Yakuji Nippo, Ltd. on August 1, 1984). Specific examples of such a carboxy vinyl polymer are those sold under the trade names Hiviswako 103, 104 and 105 by Wako Pure Chemical Industry Co., Ltd. and those sold under the trade names Carbopol 934, 940 and 941 by B. F. Goodrich Chemical Co. (Cleaveland, Ohio, U. S. A.). These carboxyl vinyl polymers generally have a free carboxyl group. An aqueous solution of the carboxy Vinyl polymer shows acidity, and when neutralized with an organic amine, it becomes a viscous gel. The content of the carboxy vinyl polymer in the gel preparation of this invention is not strict, and can be varied widely according to the contents of the other in ingredients. The suitable amount of the polymer is generally 0.1 to 3t by weight, preferably 0.3 to 2% by weight, more preferably 0.4 to 1% by weight, based on the weight of the gel preparation. From the viewpoint of the viscosity of the final gel preparation, it is desirable to adjust the content of the carboxy vinyl polymer so that the viscosity of the gel preparation at 2OOC becomes generally 4,000 to 100,000 centipoises, preferably 10,000 to 50,000 centipoises. The organic amine to be used for neutralization of the carboxy vinyl polymer is suitably water-soluble. Specific examples include mono-lower alkanolamines such as monomethanolamine, monoethanolamine, monopropanolamine and monoisopropanol amine; di-lower alkanolamines such as dimethanolamine, diethanolamine, dipropanolamine, diisopropanolamine, dibutanolamine, diisobutanolamine and di-sec-butanolamine; tri-(lower alkanol)amines such as trimethanolamine, triethanolamine, tripropanolamine, triisopropanolamine, tributanolamine, triisobutanolamine and tri-sec-butanolamine; mono-lower alkylamines such as methylamine, ethylamine, propylamine and isopropylamine; di-lower alkylamines such as dimethylamine, diethylamine, dipropylamine and diisopropylamine; and trilower alkylamines such as trimethylamine, triethylamine, tripropylamine and triisopropylamine. Of these, the mono- or di-lower alkanolamines are preferred, and mono- or di-isopropanolamine is most preferred. These amines may be used singly or as a combination of two or more. The organic amine can be used in an amount required to neutralize the carboxy vinyl polymer at least partly, or in an amount slightly in excess of it. Specifically, it is advantageously used in.an amount such that the pE of the final gel preparation becomes 5 to 10, preferably 7 to 9.5. The amount of the organic amine, which depends upon its type, the content of the carboxy vinyl polymer, etc. is generally 0.1 to 58 by weight, preferably 0.2 to 4% by weight, more preferably 0.3 to 3% by weight, based on the weight of the gel preparation. As required and desirably, the gel preparation of this invention may contain purified water. The term wpuri- fied water", as used herein, denotes water obtained by distilling ordinary water or passing it through an ion-exchange resin. Purified water serves as a solvent for the carboxy vinyl polymer and is useful for increasing the affinity of the gel preparation for the skin. Accordingly, purified water is conveniently used in an amount of generally not more than 40% by weight, preferably 3 to 35% by weight, more preferably 5 to 30% by weight, based on the weight of the gel preparation. The gel preparation of this invention is generally a transparent gel, and its typical compositions and proper- ties are as shown in the following table. Table 1 Component General Preferred Most preferred range range range(wt.%) (wot.8) (wt.%) (wt.%) ¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯ Clotrimazole 0.5-3 1-2.5 1.0-2.0 or Bifonazole 0.5-3 1-2.5 1.0-2.0 Carboxy vinyl 0.1-3 0.3-2 0.4-1 polymer Organic amine 0.1-5 0.2-4 0.3-3 1,3-Butylene 5-90 30-80 40-70 glycol Ethyl alcohol (30 5-30 10-29 Purified water (40 3-35 5-30 Total 100 100 100 - pH 5-10 Preferably 7-9.5 Viscosity (centipoises 4,000-1000,000, preferably 10,000-50,000 at 20 C) The gel preparation of this invention can be produced by mixing the aforesaid ingredients with each other until a uniform mixture forms. It can be produced by dissolving clotrimazole or bifonazole in 1,3-butylene glycol, adding the carboxy vinyl polymer to the 1,3-butylene glycol solution, and adding the organic amine to the mixture with stirring. Preferably, clotrimazole or bifonazole are first dissolved in 1,3-butylene glycol. In the dissolving step, the dissolving can preferably be promoted by heating the materials to about a temperature range of 200C to 900C, preferably to 50-850C, especially preferred to about 70 to 800C. Then, as required and preferably, ethyl alcohol is added to the 1,3-butylene glycol solution. Furthermore, the carboxy vinyl polymer is added in the form of an aqueous solution or a dispersion in 1,3-butylene glycol and purified water, preferably as the aqueous solution. Thereafter, the organic amine is preferably added in the form of an aqueous solution or an ethyl alcohol solution to the mixture, and they are fully mixed with stirring. The addition of the organic amine led to the neutralization of the carboxy vinyl polymer, and the consistency of the mixture increases. As a result, a generally transparent gel-like preparation having the individual ingredients uniformly dispersed therein is obtained. When the carboxy vinyl polymer is used in the form of an aqueous solution, its suitable concentration is generally 0.5 to 10% by weight, preferably 1 to 5% by weight. Also preferably the organic amine is added as required and desirably to the 1,3-butylene glycol solution of clotrimazole or bifonazole so prepared, and thereafter, the carboxy vinyl polymer is added in the form of an aqueous solution or a dispersion in 1,3-butylene glycol or a mixture of 1,3butylene glycol and purified water (preferably as the aqueous solution). They are fully mixed, e.g. with stirring to form the gel preparation of this invention. The method for the production of an antimycotic gel preparation therefore is also subject ot the present invention. Preferred are the embodiments specifically described above. Also the use and the method of use of the gel formulation, as an antimycoticum is a subject of the present invention. The gel preparations provided by this invention permit very good penetration and migration (absorption) of-clotrimaiole or bifonazole through the skin and exhibit a high level of antimycotic activity. They have a refreshing use feeling, little side-effects such as skin irritation and excellent storage stability. Hence, they are very useful for practical purposes. Such effects of the gel preparations are demonstrated by the following''test results obtained by using the gel preparation produced in Example 7 below. (1) Stability test The clotrimazole gel preparation of this invention (Example 7) was filled in an aluminum tube (contents 1 g), and stored in a constant temperature/humidity chamber kept at a temperature of 40 C and a relative humidity of 75%. It was reqularly taken out, an2 the amounts of clotrimazole in the gel preparation and the decomposition product of clotrimazole (o-chlorophenylcarbinol) in it were determined by high-performance liquid chromatography. The results are shown in Table 1. Table 1 EMI10.1 <tb> <SEP> Lot <SEP> 1 <SEP> 2 <SEP> 3 <tb> <SEP> Amount <SEP> (%) <SEP> Amount <SEP> (%) <SEP> Amount <SEP> (%) <tb> Test <SEP> Clotri- <SEP> Decomp- <SEP> Clotri- <SEP> Decomp- <SEP> Clotri- <SEP> Decomp <tb> <SEP> item <SEP> mazole <SEP> osition <SEP> mazole <SEP> osition <SEP> mazole <SEP> osition <tb> <SEP> (*1) <SEP> product <SEP> product <SEP> product <tb> <SEP> (*2) <tb> <SEP> S <tb> <SEP> t <SEP> weeks <SEP> <SEP> 99.2 <SEP> 0.1 <SEP> 99.4 <SEP> 0.2 <SEP> 98.8 <SEP> 0.2 <tb> <SEP> weeks <tb> <SEP> r <SEP> 8 <tb> <SEP> a <SEP> weeks <SEP> 99.2 <SEP> 0.3 <SEP> 99.3 <SEP> 0.2 <SEP> 99.6 <SEP> 0.2 <tb> <SEP> g <SEP> <tb> e <SEP> # <SEP> 12 <tb> <SEP> weeks <SEP> 99.6 <SEP> 0.4 <SEP> 100.0 <SEP> <tb> <SEP> e <tb> <SEP> r <SEP> 20 <SEP> 98.5 <SEP> 0.7 <SEP> 99.3 <SEP> 0.6 <SEP> 99.0 <SEP> 0.5 <tb> <SEP> i <SEP> weeks <tb> o <SEP> 28 <SEP> 98.7 <SEP> 0.9 <SEP> 99.3 <SEP> 0.8 <SEP> 98.5 <SEP> 0.7 <tb> d <SEP> weeks <tb> (*1): Content of clotrimazole (*2): Content of o-chlorohenylcarbinol (the decomposition product of clotrimazole) It is seen from Table 1 that when the gel preparation of this invention was stored for 28 weeks at 400C, the amount of o-chlorophenylcarbinol, the decomposition product of clotrimazole, formed was less than 1%, and it had excellent chemical stability. (2) Primary skin irritation test The primary skin irritation rate in rabbits was measured in accordance with the method of Draize et al. (see Draize, J. H., et al. 1944, Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes, J. Pharmacol. Exp. Ther. 83; 377-390). The primary skin irritation rate is a value calculated by dividing by 4 the sum of evaluation points of intact (I) skin and abraded (A) skin assigned after the lapse of 24 hours and 72 hours respectively after application of the drug. The results are shown in Table 2 below. Usually, primary skin irritation rates of at least 2.0 are regarded as indicating the presence of irritation (see Yasuhiko Shirasu et al., Environmental Toxicology: Method and Safety Evaluation, pages 444-449, Soft Science Co., Ltd., 1975). Table 2 EMI12.1 <SEP> Erythema <SEP> Edema <SEP> Incrustation <SEP> Total <SEP> Primary <tb> Rabbit <SEP> Skin <SEP> skin <SEP> ir No. <SEP> ritation <tb> <SEP> After <SEP> After <SEP> After <SEP> After <SEP> After <SEP> After <SEP> After <SEP> After <SEP> rate <tb> <SEP> 24 <SEP> 24 <SEP> 24 <SEP> 24 <SEP> 24 <SEP> 24 <SEP> 24 <SEP> 24 <tb> <SEP> hours <SEP> hours <SEP> hours <SEP> hours <SEP> hours <SEP> hours <SEP> hours <SEP> hours <tb> <SEP> 1 <SEP> Intact <SEP> (I) <SEP> 2 <SEP> 0 <SEP> 2 <SEP> 0 <SEP> 0 <SEP> 1 <tb> <SEP> Abraded <SEP> (A) <SEP> 2 <SEP> 0 <SEP> 2 <SEP> 0 <SEP> 0 <SEP> 1 <SEP> 8 <SEP> 2 <SEP> 2.50 <tb> <SEP> 2 <SEP> I <SEP> 1 <SEP> 1 <SEP> 0 <SEP> 0 <SEP> 0 <SEP> 0 <tb> <SEP> A <SEP> 1 <SEP> 1 <SEP> 2 <SEP> 1 <SEP> 0 <SEP> 1 <SEP> 4 <SEP> 4 <SEP> 2.00 <tb> <SEP> 3 <SEP> I <SEP> 1 <SEP> 0 <SEP> 0 <SEP> 0 <SEP> 0 <SEP> 0 <tb> <SEP> A <SEP> 1 <SEP> 0 <SEP> 1 <SEP> 0 <SEP> 0 <SEP> 0 <SEP> 3 <SEP> 0 <SEP> 0.75 <tb> <SEP> 4 <SEP> I <SEP> 1 <SEP> 0 <SEP> 0 <SEP> 0 <SEP> 0 <SEP> 0 <tb> <SEP> A <SEP> 1 <SEP> 0 <SEP> 1 <SEP> 0 <SEP> 0 <SEP> 0 <SEP> 3 <SEP> 0 <SEP> 0.75 <tb> <SEP> 5 <SEP> I <SEP> 1 <SEP> 0 <SEP> 0 <SEP> 0 <SEP> 0 <SEP> 0 <tb> <SEP> A <SEP> 1 <SEP> 0 <SEP> 2 <SEP> 0 <SEP> 0 <SEP> 1 <SEP> 4 <SEP> 1 <SEP> 1.25 <tb> <SEP> 6 <SEP> I <SEP> 1 <SEP> 0 <SEP> 0 <SEP> 0 <SEP> 0 <SEP> 0 <tb> <SEP> A <SEP> 1 <SEP> 0 <SEP> 2 <SEP> 0 <SEP> 0 <SEP> 1 <SEP> 4 <SEP> 1 <SEP> 1.25 <tb> Average <SEP> value <SEP> # <SEP> standard <SEP> deviation <SEP> 1.42#0.70 <tb> The results in Table 2 demonstrate that the gel preparation of this invention showed a primary skin irritation rate of 1.42+0.70 (n=6), and thus had little skin irritation. The following examples further illustrate the present invention. In these examples, ethyl alcohol used was 95% by volume ethyl alcohol, and water used was one purified on an ion-exchange resin purified water). The viscosity was measured at 200C by means of a VT-type viscometer (a product of Haake Company, U. S. A.). The carboxy vinyl polymer used was Carbopol 940 produced by B. F. Goodrich Chemical Co. EXAMPLE 1 Clotrimazole (1 g) was dissolved in 10 g of 1,3butylene glycol heated at 65 to 75 0C, and 30 g of ethyl alcohol was added to the solution. The mixture was stirred to form a uniform solution. Then, 20 g of a 2.5E aqueous solution of carboxy vinyl polymer was added, and the mixture was well stirred. Then, 9 g of a 10% aqueous solution of diisopropanolamine was added, and further 1,3-butylene glycol was added to adjust the total amount to 100 g. After thorough stirring, a transparent gel preparation was obtained which had a viscosity of 32,000 centipoises and a pH of 9.3. EXAMPLE 2 Clotrimazole (lg ) was dissolved in 20 g of 1,3butylene glycol heated at 65 to 75 0C, and 20 g of ethyl alcohol was added to it. The mixture was stirred to form a uniform solution. Then, 12.5 g of a 4% aqueous solution of carboxy vinyl polymer was added, and the mixture was well stirred. To the mixture was added 13 g of a 10% aqueous solution of triisopropanolamine, and 1,3-butylene glycol was further added to adjust the total amount to 100 g. After thorough stirring, a transparent gel preparation was obtained which had a viscosity of 30,000 centipoises and a pH of 8.3. EXAMPLE 3 Clotrimazole (1 g) was dissolved in 20 g of 1,3butylene glycol heated at 65 to 75 0C, and 10 g of ethyl alcohol was added. The mixture was stirred, and 1 g of triethanolamine was further added to form a uniform solution. Then, 30 g of a 2.5% aqueous solution of carboxy vinyl polymer was added, and the mixture was well stirred. Furthermore, 1,3-butylene glycol was added to adjust the total amount to 100 g. After thorough stir ring, a transparent gel preparation was obtained which had a viscosity of 38,000 centipoises and a pH of 7.4. EXAMPLE 4 Clotrimazole (2 g) was dissolved in 40 g of 1,3butylene glycol heated at 65 to 75 C, and 0.5 g of monoethanonlamine was further added to form a uniform solution. To the solution was added 30 g pf a 2.5% aqueous solution of carboxy vinyl polymer, and the mixture was well stirred. Furthermore, 1,3-butylene glycol was added to adjust the total amount to l00 g. After thorough stirring, a transparent gel preparation was obtained which had a viscosity of 28,000 centipoises and a pH of 6.5. EXAMPLE 5 Clotrimazole (1 g) was dissolved in 30 g of 1,3butylene glycol heated at 65 to 75 0C to form a uniform solution. To the solution was added 40 g of a 2% suspension of carboxy vinyl polymer in 1,3-butylene glycol, and the mixture was well stirred. Eight grams of a 10% aqueous solution of diisopropanolamine was added, and the mixture was well stirred. Furthermore, 1,3-butylene glycol was added to adjust the total amount to 100 g. After thorough stirring, a transparent gel preparation was obtained which had a viscosity of 25,000 centipoises and a pH of 7.5. EXAMPLE 6 Clotrimazole (1 g) was dissolved in 10 g of 1,3butylene glycol heated at 65 to 75 0C. After cooling, 10 g of ethyl alcohol was added, and the mixture was stirred to form a uniform solution. Then, 60.5 g of a dispersion of 0.5 g of carboxy vinyl polymer in 40 g of 1,3-butylene glycol and 20 g of purified water was added, and the mixture was well stirred. Then, 18 g of a 5% ethyl alcohol solution of diisopropanolamine was added, and 1,3-butylene glycol was further added to adjust the total amount to 100 g. After thorough stirring, a transparent gel preparation was obtained which had a viscosity of 31,000 centipoises and a pH of 9.0. EXAMPLE 7 Clotrimazole (1 g) was dissolved in 10 g of 1,3butylene glycol heated at 65 to 75 C. After cooling, 30 g of ethyl alcohol was added, and the mixture was stirred. Furthermore, 0.9 g of diisopropanolamine was added, and the mixture was stirred to form a uniform solution. Thereafter, 55.5 g of a dispersion of 0.5 g of carboxy vinyl polymer in 35 g of 1,3-butylene glycol and 20 g of purified water was added, and the mixture was stirred. Furthermore, 1,3-butylene glycol was added to adjust the total amount to 100 g. After thorough stirring, a transparent gel preparation was obtained which had a viscosity of 30,000 centipoises and a pH of 9.0. EXAMPLE 8 Carboxy vinyl polymer (0.8 g) was dissolved in 40 g of 1,3-butylene glycol and 20 g of purified water to form a unifrom solution. Then, 1 g of clotrimazole was dissolved in 10 g of 1,3-butylene glycol heated at 65 to 750C. After cooling, 25 g of ethyl alcohol was added, and the mixture was stirred. Furthermore, 1.4 g of diisopropanolamine was dissolved, and the resulting solution was added to the carboxy vinyl polymer solution prepared as above. The mixture was stirred, and 1,3-butylene glycol was added to adjust the total amount to 100 g. After thorough stirring, a transparent gel preparation was obtained which had a viscosity of 43,000 centipoises and a pH of 9.0. EXAMPLE 9 Carboxy vinyl polymer (0.8 g) was dissolved in 35 g of 1,3-butylene glycol, 15 g of ethyl alcohol and 20 g of purified water to form a uniform solution. Then, clotrimazole (1 g) was dissolved in 10 g of 1,3-butylene glycol heated at 65 to 75 C. After cooling, 15 g of ethyl alcohol was added, and the mixture was stirred. Furthermore, 1.4 g of diisopropanolamine was dissolved. The resulting solution was added to the carboxy vinyl polymer solution prepared as above, and the mixture was stirred. Furthermore, 1,3-butylene glycol was added to adjust the total amount to 100 g. After thorough stirring, a transparent gel preparation was obtained which had a viscosity of 41,000 centipoises and a pH of 9.0. EXAMPLE 10 Carboxy vinyl polymer (0.5 g) was dissolved in 35 g of 1,3-butylene glycol and 20 g of purified water to form a uniform solution. Then, 1 g of clotrimazole was dissolved in 10 g of 1,3-butylene glycol heated at 65 to 75 C. After cooling, 30 g of ethyl alcohol was added, and the mixture was stirred. Furthermore, 0.9 g of diisopropanolamine was dissolved. The resulting solution was added to the 'carboxy vinyl polymer solution prepared as above, and the mixture was stirred. Furthermore, 1,3-butylene glycol was added to adjust the total amount to 100 g. After thorough stirring, a transparent gel preparation was obtained which had a viscosity of 30,500 centipoises and a pH of 9.0. EXAMPLE 11 Bifonazole (1 g) was dissolved in 10 g of 1,3butylene glycol heated at about 70 C and 30 g of ethyl alcohol was added to the solution. The mixture was stirred to form a uniform solution. Then, 20 g of a 2.5t aqueous solution of carboxy vinyl polymer was added, and the mixture was well stirred. Then, 9 g of a 10% aqueous solution of diisopropanolamine was added, and further 1,3-butylene glycol was added to adjust the total amount to 100 g. After thorough stiring, a transparent gel preparation was obtained. EXAMPLE 12 Bifonazole (.lug ) was dissolved in 20 g of 1,3butylene glycol heated at about 700C and 20 g of ethyl alcohol was added to it. The mixture was stirred to form a uniform solution. Then, 12.5 g of a 4% aqueous solution of carboxy vinyl polymer was added, and the mixture was well stirred. To the mixture was added 13 g of a 10% aqueous solution of triisopropanolamine, and 1,3-butylene glycol was further added to adjust the total amount to 100 g. After thorough stirring, a transparent gel preparation was obtained. EXAMPLE 13 Bifonazole (1 g) was dissolved in 20 g of 1,3butylene glycol heated at about 700C and 10 g of ethyl alcohol was added. The mixture was stirred, and 1 g of triethanolamine was further added to form a uniform solution. Then, 30 g of a 2.5% aqueous solution of carboxy vinyl polymer was added, and the mixture was well stirred. Furthermore, 1,3-butylene glycol was added to adjust the total amount to 100 g. After thorough stirring, a transparent gel preparation was obtained. EXAMPLE 14 Bifonazole (2 g) was dissolved in 40 g of 1,3butylene glycol heated at about 70 C and 0.5 g of monoethanolamine was further added to form a uniform solution. To the solution was added 30 g pf a 2.5% aqueous solution of carboxy vinyl polymer, and the mixture was well stirred. Furthermore', 1,3-butylene glycol was added to adjust the total amount to 100 g. After thorough stirring, a transparent gel preparation was obtained. EXAMPLE 15 Bifonazolel g) was dissolved in 30 g of 1,3butylene glycol heated at about 700C to form a uniform solution. To the solution was added 40 g of a 2% suspension of carboxy vinyl polymer in 1,3-butylene glycol, and the mixture was well stirred. Eight grams of a 10% aqueous solution of diisopropanolamine was added, and the mixture was well stirred. Furthermore, 1,3-butylene glycol was added to adjust the total amount to 100 g. After thorough stirring, a transparent gel preparation was obtained. EXAMPLE 16 Bifonazole(l g) was dissolved in 10 g of 1,3butylene glycol heated at about 70 C After cooling, 10 g of ethyl alcohol was added, and the mixture was stirred to form a uniform solution. Then, 60.5 g of a dispersion of 0.5 g Of carboxy vinyl polymer in 40 g of 1,3-butylene glycol and 20 g of purified water was added, and the mixture was well stirred. Then, 18 g of a 5% ethyl alcohol solution of diisopropanolamine was added, and 1,3-butylene glycol was further added to adjust the total amount to 100 g. After thorough stirring, a transparent gel preparation was obtained. EXAMPLE 17 Bifonazole (1 g) was dissolved in 10 g of 1,3butylene glycol heated at about 700C. After cooling, 30 g of ethyl alcohol was added, and the mixture was stirred. Furthermore, 0.9 g of diisopropanolamine was added, and the mixture was stirred to form a uniform solution. Thereafter, 55.5 g of a dispersion of 0.5 g of carboxy vinyl polymer in 35 g of 1,3-butylene glycol and 20 g of purified water was added, and the mixture was stirred. Furthermore, 1,3-butylene glycol was added to adjust the total amount to 100 g. After thorough stirring, a transparent gel preparation was obtained. EXAMPLE 18 Carboxy vinyl polymer (0.8 g) was dissolved in 40 g of 1,3-butylene glycol and 20 g of purified water to form a unifrom solution. Then, 1 g of bifonazole was dissolved in 10 g of 1,3-butylene glycol heated at about 700C After cooling, 25 g of ethyl alcohol was added, and the mixture was stirred. Furthermore, 1.4 g of diisopropanolamine was dissolved, and the resulting solution was added to the carboxy vinyl polymer solution prepared as above. The mixture was stirred, and 1,3-butylene glycol was added to adjust the total amount to 100 g. After thorough stirring, a transparent gel preparation was obtained. EXAMPLE 19 Carboxy vinyl polymer (0.8 g) was dissolved in 35 g of 1,3-butylene glycol, 15 g of ethyl alcohol and 20 g of purified water to form a uniform solution. Then, bifonazole (1 g) was dissolved in 10 g of 1,3-butylene glycol heated at about 700C After cooling, 15 g of ethyl alcohol was added, and the mixture was stirred. Furthermore, 1.4 g of diisopropanolamine was dissolved. The resulting solution was added to the carboxy vinyl polymer solution prepared as above, and the mixture was stirred. Furthermore, 1,3-butylene glycol was added to adjust the total amount to 100 g. After thorough stirring, a transparent gel preparation was obtained. EXAMPLE 20 Carboxy vinyl polymer (0.5 g) was dissolved in 35 g of 1,3-butylene glycol and 20 g of purified water to form a uniform solution. Then, 1 g of bifonazole was dissolved in 10 g cf 1,3-butylene glycol heated at about 700C. After cooling, 30 g of ethyl alcohol was added, and the mixture was stirred. Furthermore, 0.9 g of diisopropanolamine was dissolved. The resulting solution was added to the carboxy vinyl polymer solution prepared as above, and the mixture was stirred. Furthermore, 1,3-butylene glycol was added to adjust the total amount to 100 g. After thorough stirring, a transparent gel preparation was obtained.

Claims: Claims: 1. An antimycotic gel preparation characterized by contai ning clotrimazole or bifonazole, a carboxy vinyl polymer, an organic amine and 1,3-butylene glycol. 2. The gel preparation of claim 1 which contains 0.5 to 3% by weight, based on the weight of the preparation, of clotrimazole or bifonazole. 3. The gel preparation of claims 1 or 2 which contains 0.1 to 3% by weight, based on the weight of the preparation, of the carboxy vinyl polymer. 4. The gel preparation of any one of claims 1 to 3 wherein the organic amine is a mono- or di-lower alkanolamine, preferably mono- or di-isopropanolamine. 5. The gel preparation of any one of claims 1 to 4 which contains 5 to 90% by weight, based on the weight of the preparation, of 1,3-butylene glycol. 6. The gel preparation of any one of claims 1 to 5 which further contains ethyl alcohol, preferably not more than 30% by weight, based on the weight of the prepa ration. 7. The gel preparation of any one of claims 1 to 6 which further contains purified water. 8. The gel preparation of any one of claims 1 to 7 which has a pH of 5 to 10 and a viscosity at 200C of 4,000 to 100,-61j0 centipoises. 9. The gel preparation of any one of claims 1 to 8 which is transparent and has a pH of 7 to 9.5 and a viscosity at 200C of 10,000 to 50,000 centipoises, and consists of 1.0 to 2.08 by weight of clotrimazole or 1.0 to 2.0% by weight of bifonazole, 0.4 to 1t by weight of diisopropanolamine, 40 to 70% by weight of 1,3-butylene glycol, 10 to 29% by weight of ethyl alcohol and 5 to 30% by weight of purified water. 10. Method for the production of an antimycotic gel prepara tion characterized in that the active ingredient clotri mazole or bifonazole are thoroughly mixed with carboxy vinyl polymer, an organic amine and 1,3-butylene glycol. 11. Use of a gel preparation containing clotrimazole or bifonazole, a carboxy vinyl polymer, an organic amine and 1,3-butylene glycol as an antimycoticum.

Inventors: HATA, HIROKO, HATTORI, TOSHIYUKI, NISHIOKA, TAKAAKI, OHARA, YOSHISHIGE, UEHARA, MINEHIKO
Applicants: BAYER AG
Application year: 1985
Main classification: A61K31
IPC codes: A61P31, A61K47, A61K31, A61K9